{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:46:20Z","timestamp":1792194380416,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,17]]},"DOI":"10.7759\/cureus.32619","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:25:56Z","timestamp":1671265556000},"source":"Crossref","is-referenced-by-count":6,"title":["The Spectrum of Treatment Modalities for Gastroesophageal Reflux Disease (GERD): A Narrative Review"],"prefix":"10.7759","author":[{"given":"Namrata R","family":"Velagala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek R","family":"Velagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashwant","family":"Lamture","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil N","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006, 101:1900-20; quiz 1943. 10.1111\/j.1572-0241.2006.00630.x","journal-title":"Am J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.70.suppl_5.s4","article-title":"GERD pathogenesis, pathophysiology, and clinical manifestations","volume":"70 Suppl 5","author":"Kahrilas PJ","year":"2003","unstructured":"Kahrilas PJ. GERD pathogenesis, pathophysiology, and clinical manifestations. Cleve Clin J Med. 2003, 70 Suppl 5:S4-19. 10.3949\/ccjm.70.suppl_5.s4","journal-title":"Cleve Clin J Med"},{"key":"ref3","article-title":"Pathophysiology and diagnosis of gastroesophageal reflux disease","volume":"50","author":"Bozymski EM","year":"1993","unstructured":"Bozymski EM. Pathophysiology and diagnosis of gastroesophageal reflux disease. Am J Hosp Pharm. 1993, 50:4-6.","journal-title":"Am J Hosp Pharm"},{"key":"ref4","article-title":"Gastroesophageal reflux  disease (GERD)","volume":"115","author":"Clarrett DM","year":"2018","unstructured":"Clarrett DM, Hachem C. Gastroesophageal reflux  disease (GERD). Mo Med. 2018, 115:214-8.","journal-title":"Mo Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05912.x","article-title":"Gastroesophageal reflux disease--should we adopt a new conceptual framework?","volume":"97","author":"Fass R","year":"2002","unstructured":"Fass R, Ofman JJ. Gastroesophageal reflux disease--should we adopt a new conceptual framework?. Am J Gastroenterol. 2002, 97:1901-9. 10.1111\/j.1572-0241.2002.05912.x","journal-title":"Am J Gastroenterol"},{"key":"ref6","article-title":"GER and GERD in children: to treat or not to treat?","volume":"67","author":"Quitadamo P","year":"2015","unstructured":"Quitadamo P, Ummarino D, Staiano A. GER and GERD in children: to treat or not to treat?. Minerva Pediatr. 2015, 67:187-97.","journal-title":"Minerva Pediatr"},{"key":"ref7","article-title":"Definition and classification of GERD [Article in Japanese]","volume":"65","author":"Hongo M","year":"2007","unstructured":"Hongo M, Shoji T. Definition and classification of GERD [Article in Japanese]. Nihon Rinsho. 2007, 65:785-90.","journal-title":"Nihon Rinsho"},{"key":"ref8","article-title":"Nonerosive reflux disease","volume":"53","author":"Long JD","year":"2007","unstructured":"Long JD, Orlando RC. Nonerosive reflux disease. Minerva Gastroenterol Dietol. 2007, 53:127-41.","journal-title":"Minerva Gastroenterol Dietol"},{"key":"ref9","article-title":"Sliding hiatal hernia in patients with gastroesophageal reflux: physiopathology and surgical treatment [Article in Italian]","volume":"55","author":"Bresadola V","year":"2000","unstructured":"Bresadola V, Noce L, Ventroni MG, Vianello V, Intini S, Bresadola F. Sliding hiatal hernia in patients with gastroesophageal reflux: physiopathology and surgical treatment [Article in Italian]. Minerva Chir. 2000, 55:415-20.","journal-title":"Minerva Chir"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag HB","year":"2014","unstructured":"El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014, 63:871-80. 10.1136\/gutjnl-2012-304269","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.32978","article-title":"The burden of selected digestive diseases in the United States","volume":"122","author":"Sandler RS","year":"2002","unstructured":"Sandler RS, Everhart JE, Donowitz M, et al.. The burden of selected digestive diseases in the United States. Gastroenterology. 2002, 122:1500-11. 10.1053\/gast.2002.32978","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5009\/gnl16615","article-title":"Current trends in the management of gastroesophageal reflux disease","volume":"12","author":"Sandhu DS","year":"2018","unstructured":"Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver. 2018, 12:7-16. 10.5009\/gnl16615","journal-title":"Gut Liver"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.32394\/rpzh.2021.0145","article-title":"Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet","volume":"72","author":"Taraszewska A","year":"2021","unstructured":"Taraszewska A. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet. Rocz Panstw Zakl Hig. 2021, 72:21-8. 10.32394\/rpzh.2021.0145","journal-title":"Rocz Panstw Zakl Hig"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2017.11","article-title":"Which drugs are risk factors for the development of gastroesophageal reflux disease?","volume":"28","author":"Mungan Z","year":"2017","unstructured":"Mungan Z, P\u0131narba\u015f\u0131 \u015eim\u015fek B. Which drugs are risk factors for the development of gastroesophageal reflux disease?. Turk J Gastroenterol. 2017, 28:S38-43. 10.5152\/tjg.2017.11","journal-title":"Turk J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00370.x","article-title":"Clinical manifestations and complications of gastroesophageal reflux disease (GERD)","volume":"59","author":"Malfertheiner P","year":"2005","unstructured":"Malfertheiner P, Hallerb\u00e4ck B. Clinical manifestations and complications of gastroesophageal reflux disease (GERD). Int J Clin Pract. 2005, 59:346-55. 10.1111\/j.1742-1241.2005.00370.x","journal-title":"Int J Clin Pract"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-008-0040-8","article-title":"ENT manifestations of gastroesophageal reflux","volume":"8","author":"Pass\u00e0li D","year":"2008","unstructured":"Pass\u00e0li D, Caruso G, Pass\u00e0li FM. ENT manifestations of gastroesophageal reflux. Curr Allergy Asthma Rep. 2008, 8:240-4. 10.1007\/s11882-008-0040-8","journal-title":"Curr Allergy Asthma Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-013-0316-6","article-title":"Ambulatory reflux monitoring in GERD--which test should be performed and should therapy be stopped?","volume":"15","author":"Gawron AJ","year":"2013","unstructured":"Gawron AJ, Pandolfino JE. Ambulatory reflux monitoring in GERD--which test should be performed and should therapy be stopped?. Curr Gastroenterol Rep. 2013, 15:316. 10.1007\/s11894-013-0316-6","journal-title":"Curr Gastroenterol Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.giec.2004.10.005","article-title":"Prolonged pH monitoring: Bravo capsule","volume":"15","author":"Pandolfino JE","year":"2005","unstructured":"Pandolfino JE, Kahrilas PJ. Prolonged pH monitoring: Bravo capsule. Gastrointest Endosc Clin N Am. 2005, 15:307-18. 10.1016\/j.giec.2004.10.005","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.23750\/abm.v89i8-S.7963","article-title":"Diagnosis of GERD in typical and atypical manifestations","volume":"89","author":"Cesario S","year":"2018","unstructured":"Cesario S, Scida S, Miraglia C, et al.. Diagnosis of GERD in typical and atypical manifestations. Acta Biomed. 2018, 89:33-9. 10.23750\/abm.v89i8-S.7963","journal-title":"Acta Biomed"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2478\/rjim-2020-0027","article-title":"Advances in the diagnosis of GERD","volume":"59","author":"S\u0103raru ER","year":"2021","unstructured":"S\u0103raru ER, Enciu V, Peagu R, Fierbin\u0163eanu-Braticevici C. Advances in the diagnosis of GERD. Rom J Intern Med. 2021, 59:3-9. 10.2478\/rjim-2020-0027","journal-title":"Rom J Intern Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.06.42","article-title":"The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn","volume":"11","author":"Newberry C","year":"2019","unstructured":"Newberry C, Lynch K. The role of diet in the development and management of gastroesophageal reflux disease: why we feel the burn. J Thorac Dis. 2019, 11:S1594-601. 10.21037\/jtd.2019.06.42","journal-title":"J Thorac Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-28032014000300010","article-title":"Acidic and neutral liquid ingestion in patients with gastroesophageal reflux disease","volume":"51","author":"Gomes DC","year":"2014","unstructured":"Gomes DC, Dantas RO. Acidic and neutral liquid ingestion in patients with gastroesophageal reflux disease. Arq Gastroenterol. 2014, 51:217-20. 10.1590\/s0004-28032014000300010","journal-title":"Arq Gastroenterol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2009.03.020","article-title":"Carbonated beverages and gastrointestinal system: between myth and reality","volume":"19","author":"Cuomo R","year":"2009","unstructured":"Cuomo R, Sarnelli G, Savarese MF, Buyckx M. Carbonated beverages and gastrointestinal system: between myth and reality. Nutr Metab Cardiovasc Dis. 2009, 19:683-9. 10.1016\/j.numecd.2009.03.020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318032bed3","article-title":"Diet and reflux","volume":"41","author":"Benamouzig R","year":"2007","unstructured":"Benamouzig R, Airinei G. Diet and reflux. J Clin Gastroenterol. 2007, 41:64. 10.1097\/MCG.0b013e318032bed3","journal-title":"J Clin Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199509000-00004","article-title":"How does chili cause upper gastrointestinal symptoms? A correlation study with esophageal mucosal sensitivity and esophageal motility","volume":"21","author":"Yeoh KG","year":"1995","unstructured":"Yeoh KG, Ho KY, Guan R, Kang JY. How does chili cause upper gastrointestinal symptoms? A correlation study with esophageal mucosal sensitivity and esophageal motility. J Clin Gastroenterol. 1995, 21:87-90. 10.1097\/00004836-199509000-00004","journal-title":"J Clin Gastroenterol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01064.x","article-title":"Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects","volume":"94","author":"Pehl C","year":"1999","unstructured":"Pehl C, Waizenhoefer A, Wendl B, Schmidt T, Schepp W, Pfeiffer A. Effect of low and high fat meals on lower esophageal sphincter motility and gastroesophageal reflux in healthy subjects. Am J Gastroenterol. 1999, 94:1192-6. 10.1111\/j.1572-0241.1999.01064.x","journal-title":"Am J Gastroenterol"},{"key":"ref27","article-title":"A comparison of high and low fat meals on postprandial esophageal acid exposure","volume":"84","author":"Becker DJ","year":"1989","unstructured":"Becker DJ, Sinclair J, Castell DO, Wu WC. A comparison of high and low fat meals on postprandial esophageal acid exposure. Am J Gastroenterol. 1989, 84:782-6.","journal-title":"Am J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/BF02091532","article-title":"Relationship between postprandial esophageal acid exposure and meal volume and fat content","volume":"41","author":"Iwakiri K","year":"1996","unstructured":"Iwakiri K, Kobayashi M, Kotoyori M, Yamada H, Sugiura T, Nakagawa Y. Relationship between postprandial esophageal acid exposure and meal volume and fat content. Dig Dis Sci. 1996, 41:926-30. 10.1007\/BF02091532","journal-title":"Dig Dis Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12384","article-title":"Adherence to a predominantly Mediterranean diet decreases the risk of gastroesophageal reflux disease: a cross-sectional study in a South Eastern European population","volume":"29","author":"Mone I","year":"2016","unstructured":"Mone I, Kraja B, Bregu A, Duraj V, Sadiku E, Hyska J, Burazeri G. Adherence to a predominantly Mediterranean diet decreases the risk of gastroesophageal reflux disease: a cross-sectional study in a South Eastern European population. Dis Esophagus. 2016, 29:794-800. 10.1111\/dote.12384","journal-title":"Dis Esophagus"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054391","article-title":"Body-mass index and symptoms of gastroesophageal reflux in women","volume":"354","author":"Jacobson BC","year":"2006","unstructured":"Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med. 2006, 354:2340-8. 10.1056\/NEJMoa054391","journal-title":"N Engl J Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2012.11.011","article-title":"Gastroesophageal reflux disease and sleep","volume":"42","author":"Fujiwara Y","year":"2013","unstructured":"Fujiwara Y, Arakawa T, Fass R. Gastroesophageal reflux disease and sleep. Gastroenterol Clin North Am. 2013, 42:57-70. 10.1016\/j.gtc.2012.11.011","journal-title":"Gastroenterol Clin North Am"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/srep41021","article-title":"Effectiveness and tolerability of Different Recommended Doses of PPIs and H(2)RAs in GERD: network meta-analysis and GRADE system","volume":"7","author":"Zhang C","year":"2017","unstructured":"Zhang C, Kwong JS, Yuan RX, et al.. Effectiveness and tolerability of Different Recommended Doses of PPIs and H(2)RAs in GERD: network meta-analysis and GRADE system. Sci Rep. 2017, 7:41021. 10.1038\/srep41021","journal-title":"Sci Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002095.pub5","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"2013","author":"Sigterman KE","year":"2013","unstructured":"Sigterman KE, van Pinxteren B, Bonis PA, Lau J, Numans ME. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2013, 2013:CD002095. 10.1002\/14651858.CD002095.pub5","journal-title":"Cochrane Database Syst Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.21360","article-title":"Gastroesophageal reflux disease: a review","volume":"324","author":"Maret-Ouda J","year":"2020","unstructured":"Maret-Ouda J, Markar SR, Lagergren J. Gastroesophageal reflux disease: a review\r\n. JAMA. 2020, 324:2536-47. 10.1001\/jama.2020.21360","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13023","article-title":"Side effects of long-term proton pump inhibitor use: a review","volume":"123","author":"Haastrup PF","year":"2018","unstructured":"Haastrup PF, Thompson W, S\u00f8ndergaard J, Jarb\u00f8l DE. Side effects of long-term proton pump inhibitor use: a review. Basic Clin Pharmacol Toxicol. 2018, 123:114-21. 10.1111\/bcpt.13023","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191610280","article-title":"Association between benign paroxysmal positional vertigo and previous proton pump inhibitor use: a nested case-control study using a national health screening cohort","volume":"19","author":"Kim SY","year":"2022","unstructured":"Kim SY, Yoo DM, Kwon MJ, Kim JH, Kim JH, Lee JS, Choi HG. Association between benign paroxysmal positional vertigo and previous proton pump inhibitor use: a nested case-control study using a national health screening cohort. Int J Environ Res Public Health. 2022, 19:10.3390\/ijerph191610280","journal-title":"Int J Environ Res Public Health"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.482932","article-title":"Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors","volume":"11","author":"Johnson DA","year":"2010","unstructured":"Johnson DA, Levy BH 3rd. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors. Expert Opin Pharmacother. 2010, 11:1541-8. 10.1517\/14656566.2010.482932","journal-title":"Expert Opin Pharmacother"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2011.01322.x","article-title":"Step-by-step management of refractory gastresophageal reflux disease","volume":"26","author":"Hershcovici T","year":"2013","unstructured":"Hershcovici T, Fass R. Step-by-step management of refractory gastresophageal reflux disease. Dis Esophagus. 2013, 26:27-36. 10.1111\/j.1442-2050.2011.01322.x","journal-title":"Dis Esophagus"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13611","article-title":"Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013","volume":"43","author":"Khan F","year":"2016","unstructured":"Khan F, Maradey-Romero C, Ganocy S, Frazier R, Fass R. Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther. 2016, 43:1124-31. 10.1111\/apt.13611","journal-title":"Aliment Pharmacol Ther"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.gtc.2021.07.005","article-title":"Endoscopic and surgical management of gastroesophageal reflux disease","volume":"50","author":"Zimmermann CJ","year":"2021","unstructured":"Zimmermann CJ, Lidor A. Endoscopic and surgical management of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2021, 50:809-23. 10.1016\/j.gtc.2021.07.005","journal-title":"Gastroenterol Clin North Am"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1080\/13645706.2021.1878538","article-title":"Complete vs partial fundoplication: a laboratory measurement of functionality and effectiveness","volume":"31","author":"Gefen R","year":"2022","unstructured":"Gefen R, Marom G, Brodie R, Elazary R, Mintz Y. Complete vs partial fundoplication: a laboratory measurement of functionality and effectiveness. Minim Invasive Ther Allied Technol. 2022, 31:635-41. 10.1080\/13645706.2021.1878538","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"ref42","article-title":"Laparoscopic Nissen fundoplication","volume":"56","author":"Pavlidis TE","year":"2001","unstructured":"Pavlidis TE. Laparoscopic Nissen fundoplication. Minerva Chir. 2001, 56:421-6.","journal-title":"Minerva Chir"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2011.01235.x","article-title":"Randomized clinical trial of laparoscopic anterior 180\u00b0 partial versus 360\u00b0 Nissen fundoplication: 5-year results","volume":"25","author":"Cao Z","year":"2012","unstructured":"Cao Z, Cai W, Qin M, Zhao H, Yue P, Li Y. Randomized clinical trial of laparoscopic anterior 180\u00b0 partial versus 360\u00b0 Nissen fundoplication: 5-year results. Dis Esophagus. 2012, 25:114-20. 10.1111\/j.1442-2050.2011.01235.x","journal-title":"Dis Esophagus"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14511","article-title":"Endoscopic treatments for GERD","volume":"1482","author":"Kushner BS","year":"2020","unstructured":"Kushner BS, Awad MM, Mikami DJ, Chand BB, Wai CJ, Murayama KM. Endoscopic treatments for GERD. Ann N Y Acad Sci. 2020, 1482:121-9. 10.1111\/nyas.14511","journal-title":"Ann N Y Acad Sci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.17116\/hirurgia202106130","article-title":"Collis gastroplasty in surgical treatment of hiatal hernia [Article in Russian]","author":"Sovpel IV","year":"2021","unstructured":"Sovpel IV, Ishchenko RV, Sedakov IE, Sovpel OV, Balaban VV. Collis gastroplasty in surgical treatment of hiatal hernia [Article in Russian]. Khirurgiia (Mosk). 2021, 30-7. 10.17116\/hirurgia202106130","journal-title":"Khirurgiia (Mosk)"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-013-3250-7","article-title":"Effect of transoral incisionless fundoplication on reflux mechanisms","volume":"28","author":"Rinsma NF","year":"2014","unstructured":"Rinsma NF, Smeets FG, Bruls DW, Kessing BF, Bouvy ND, Masclee AA, Conchillo JM. Effect of transoral incisionless fundoplication on reflux mechanisms. Surg Endosc. 2014, 28:941-9. 10.1007\/s00464-013-3250-7","journal-title":"Surg Endosc"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2008.07.034","article-title":"A new injectable agent for the treatment of GERD: results of the Durasphere pilot trial","volume":"69","author":"Ganz RA","year":"2009","unstructured":"Ganz RA, Fallon E, Wittchow T, Klein D. A new injectable agent for the treatment of GERD: results of the Durasphere pilot trial. Gastrointest Endosc. 2009, 69:318-23. 10.1016\/j.gie.2008.07.034","journal-title":"Gastrointest Endosc"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1586\/17434440.2.1.19","article-title":"Enteryx for gastroesophageal reflux disease","volume":"2","author":"Johnson DA","year":"2005","unstructured":"Johnson DA. Enteryx for gastroesophageal reflux disease. Expert Rev Med Devices. 2005, 2:19-26. 10.1586\/17434440.2.1.19","journal-title":"Expert Rev Med Devices"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.2147\/MDER.S113679","article-title":"Spotlight on the Linx\u2122 Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research","volume":"11","author":"Zadeh J","year":"2018","unstructured":"Zadeh J, Andreoni A, Treitl D, Ben-David K. Spotlight on the Linx\u2122 Reflux Management System for the treatment of gastroesophageal reflux disease: evidence and research. Med Devices (Auckl). 2018, 11:291-300. 10.2147\/MDER.S113679","journal-title":"Med Devices (Auckl)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/121314-the-spectrum-of-treatment-modalities-for-gastroesophageal-reflux-disease-gerd-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:18Z","timestamp":1707507978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/121314-the-spectrum-of-treatment-modalities-for-gastroesophageal-reflux-disease-gerd-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.32619","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,17]]}}}